BSEM Share Price Performance
US$4.83
-9.04 (-65.18%)
86.4% undervalued intrinsic discount
US$35.50
Fair Value
Price US$4.83
AnalystConsensusTarget US$35.50
Fair ValueUS$49.56
Share Pricen/a
BioStem Technologies, Inc. Stock Price
- 1 Narratives written by author
- 1 Comments on narratives written by author
- 41 Fair Values set on narratives written by author
BSEM Community Narratives
AN
Fair Value US$49.56 90.3% undervalued intrinsic discount
VENDAJE AC National Launch And BioRetain Data To Drive Future Market Expansion
0users have liked this narrative
1users have commented on this narrative
17users have followed this narrative
VENDAJE AC National Launch And BioRetain Data To Drive Future Market Expansion
Key Takeaways Strategic collaborations and successful CMS partnerships can enhance market adoption and pricing stability, boosting net margins and profitability. Expanding clinical trials and NASDAQ uplisting may increase revenue, earnings, and shareholder value through broader market access and investor reach.Read more
0users have liked this narrative
1users have commented on this narrative
17users have followed this narrative
AN
US$49.56
90.3% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue
27% p.a.
Profit Margin
11.67%
Future PE
13.13x
Price in 2028
US$37.76
Trending Discussion
Recently Updated Narratives
AN
VENDAJE AC National Launch And BioRetain Data To Drive Future Market Expansion
Fair Value: US$49.56 90.3% undervalued intrinsic discount
17 followersusers have followed this narrative
1 commentusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
BioStem Technologies, Inc. Key Details
About BSEM
- Founded
- 2006
- Employees
- n/a
- CEO
- WebsiteView website
BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave’s Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.
